Eli Lilly calls on Britain’s health service to pay higher prices for medicines
Copy link
NHS risks missing out on new drugs, warns Mounjaro maker
Eli Lilly calls on Britain’s health service to pay higher prices for medicines
503 words~2 min read
Related reading
Mounjaro manufacturer blasts UK as ‘worst country in Europe’ for drug prices
The boss of Eli Lilly, Dave Ricks, warns that Britain will miss out on new drugs as a result of pricing issues
UK is ‘worst country in Europe’ for drug prices, says Mounjaro maker
Eli Lilly CEO says Britain’s strict regime means it could miss out on new drugs being rolled out unless it pays more
Drugmaker pauses UK sales of weight-loss jab Mounjaro
Eli Lilly halts orders as British patients race to beat looming price rise
NHS must pay ‘fair share’, says US drug giant amid Trump pressure
Drugmaker echoes president’s insistence that overseas health services fund new treatments
NHS pricing row has made Britain unattractive, says drugs giant
The UK’s uncompetitive policies have led to years of chronic underinvestment
Eli Lilly raises UK price of weight-loss drug Mounjaro by up to 170%
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines
